RU2007100833A - METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD - Google Patents

METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD Download PDF

Info

Publication number
RU2007100833A
RU2007100833A RU2007100833/14A RU2007100833A RU2007100833A RU 2007100833 A RU2007100833 A RU 2007100833A RU 2007100833/14 A RU2007100833/14 A RU 2007100833/14A RU 2007100833 A RU2007100833 A RU 2007100833A RU 2007100833 A RU2007100833 A RU 2007100833A
Authority
RU
Russia
Prior art keywords
years old
dose
day
children
facial nerve
Prior art date
Application number
RU2007100833/14A
Other languages
Russian (ru)
Other versions
RU2348401C2 (en
Inventor
Наталья Викторовна Скрипченко (RU)
Наталья Викторовна Скрипченко
Дмитрий Александрович Голяков (RU)
Дмитрий Александрович Голяков
Надежда Федоровна Пульман (RU)
Надежда Федоровна Пульман
Марина Витальевна Иванова (RU)
Марина Витальевна Иванова
Елена Александровна Мурина (RU)
Елена Александровна Мурина
Николай Валерьевич Моргацкий (RU)
Николай Валерьевич Моргацкий
Original Assignee
Федеральное Государственное Учреждение Научно-исследовательский институт детских инфекций (RU)
Федеральное Государственное Учреждение Научно-исследовательский институт детских инфекций
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное Государственное Учреждение Научно-исследовательский институт детских инфекций (RU), Федеральное Государственное Учреждение Научно-исследовательский институт детских инфекций filed Critical Федеральное Государственное Учреждение Научно-исследовательский институт детских инфекций (RU)
Priority to RU2007100833/14A priority Critical patent/RU2348401C2/en
Publication of RU2007100833A publication Critical patent/RU2007100833A/en
Application granted granted Critical
Publication of RU2348401C2 publication Critical patent/RU2348401C2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способ лечения инфекционной невропатии лицевого нерва в остром периоде путем проведения комплексной патогенетической терапии, отличающийся тем, что дополнительно перорально одновременно назначают амиксин детям с 7 до 12 лет в дозе 0,06 г 1 раз в сутки, взрослым и детям старше 12 лет в дозе 0,125 г 1 раз в сутки в течение 2 недель, нурофен: детям до 12 лет в разовой дозе 10 мг/кг/массы тела 2-3 раза в сутки, взрослым и детям старше 12 лет в дозе 200 мг 2-3 раза в сутки в течение 2 недель.A method for the treatment of infectious neuropathy of the facial nerve in the acute period by conducting complex pathogenetic therapy, characterized in that additionally orally administered amiksin to children from 7 to 12 years old at a dose of 0.06 g once a day, adults and children over 12 years old at a dose of 0.125 g 1 time per day for 2 weeks, nurofen: for children up to 12 years old in a single dose of 10 mg / kg / body weight 2-3 times a day, for adults and children over 12 years old at a dose of 200 mg 2-3 times a day in within 2 weeks.

Claims (1)

Способ лечения инфекционной невропатии лицевого нерва в остром периоде путем проведения комплексной патогенетической терапии, отличающийся тем, что дополнительно перорально одновременно назначают амиксин детям с 7 до 12 лет в дозе 0,06 г 1 раз в сутки, взрослым и детям старше 12 лет в дозе 0,125 г 1 раз в сутки в течение 2 недель, нурофен: детям до 12 лет в разовой дозе 10 мг/кг/массы тела 2-3 раза в сутки, взрослым и детям старше 12 лет в дозе 200 мг 2-3 раза в сутки в течение 2 недель.A method for the treatment of infectious neuropathy of the facial nerve in the acute period by conducting complex pathogenetic therapy, characterized in that additionally orally administered amiksin to children from 7 to 12 years old at a dose of 0.06 g once a day, adults and children over 12 years old at a dose of 0.125 g 1 time per day for 2 weeks, nurofen: for children up to 12 years old in a single dose of 10 mg / kg / body weight 2-3 times a day, for adults and children over 12 years old at a dose of 200 mg 2-3 times a day in within 2 weeks.
RU2007100833/14A 2007-01-09 2007-01-09 Method of treatment of acute viral facial nerve neuropathy RU2348401C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2007100833/14A RU2348401C2 (en) 2007-01-09 2007-01-09 Method of treatment of acute viral facial nerve neuropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007100833/14A RU2348401C2 (en) 2007-01-09 2007-01-09 Method of treatment of acute viral facial nerve neuropathy

Publications (2)

Publication Number Publication Date
RU2007100833A true RU2007100833A (en) 2008-07-20
RU2348401C2 RU2348401C2 (en) 2009-03-10

Family

ID=40528826

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007100833/14A RU2348401C2 (en) 2007-01-09 2007-01-09 Method of treatment of acute viral facial nerve neuropathy

Country Status (1)

Country Link
RU (1) RU2348401C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2538083C1 (en) * 2013-08-20 2015-01-10 Анастасия Александровна Николаева Method of treating affection of vegetative parasympathetic nodes of head of herpes-virus etiology
RU2695000C1 (en) * 2018-07-17 2019-07-18 Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" Method for prediction of facial nerve recovery in neuropathy in children

Also Published As

Publication number Publication date
RU2348401C2 (en) 2009-03-10

Similar Documents

Publication Publication Date Title
MX344476B (en) Methods of treating pulmonary disorders with liposomal amikacin formulations.
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
GEP201706786B (en) Methods and drug products for treating alzheimer's disease
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
RU2014150942A (en) TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE
JP2018090566A5 (en)
MX2022015629A (en) Use of vibegron to treat overactive bladder.
MX2023000187A (en) Dosing of vibegron for treatment of overactive bladder.
MX2021002322A (en) Novel methods.
RU2007100833A (en) METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD
JP2019529569A5 (en)
CL2023000296A1 (en) Use of dexpramipexole for the treatment of moderate to severe asthma
IL194346A0 (en) Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application
MX2012005497A (en) Tivozanib and temsirolimus in combination.
EA202190724A1 (en) KETAMINE-BASED PREPARATION FOR TREATMENT OF DEPRESSION BY INHALATION
MX2021007324A (en) Oral therapy using 6,8-bis-benzylthio-octanoic acid.
MX2010006310A (en) O-desmethyl-venlafaxine for treating major depressive disorder.
MD3422G2 (en) Method of prophylaxis and treatment of gallinaceae knemidokoptosis
RU2007116477A (en) METHOD FOR TREATMENT OF BACTERIAL PURULENT MENITITIS IN CHILDREN
MX2020001217A (en) Methods of treating symptoms of gastroparesis using velusetrag.
RU2012123673A (en) METHOD FOR REGULATING EXCHANGE OF SUBSTANCES
RU2009119225A (en) METHOD OF TREATMENT AND PREVENTION OF COCKIDIOSIS OF MINK
RU2008107113A (en) MEANS AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090110